Evidence map›Paper›PMID 41413915›Full record

Trial reportBMC psychology2025

Cognitive behavioral therapy, exercise training, and cognitive remediation for patients with post-COVID-19 condition: protocol of an open-label randomized controlled trial.

Clément Gouraud, Agathe Ancellin-Geay, Corentin Verot, Isabelle Bergeras, Laura Poudevigne, Lucile Cormier, Séverine Gilbert, Frédéric Limosin, Laurence Lacoste, Diane Ribayrol and 9 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05532904 (Evaluation and Comparison of Multidisciplinary Day-hospital Versus Waiting List Management of Persistent Symptoms After an Acute Episode of COVID-19), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05532904 nacompletednot on this map

Evaluation and Comparison of Multidisciplinary Day-hospital Versus Waiting List Management of Persistent Symptoms After an Acute Episode of COVID-19

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2023 to 2025Enrolled80ConditionsPost COVID-19 ConditionArmsPersonalized multidisciplinary day-hospital intervention
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Clément GouraudService de Psychiatrie de L'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, 75004, France. clement.gouraud@aphp.fr.
Agathe Ancellin-GeayService de Psychiatrie de L'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, 75004, France.
Corentin VerotCIMS (Centre d'Investigations en Médecine du Sport), APHP, Hôpital Hôtel Dieu, Paris, 75004, France.
Isabelle BergerasService de Psychiatrie Et d'Addictologie de L'adulte Et du Sujet Âgé, AP-HP, Hôpital Corentin Celton, Issy-Les-Moulineaux, 92130, France.
Laura PoudevigneService de Psychiatrie de L'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, 75004, France.
Lucile CormierService de Psychiatrie Et d'Addictologie de L'adulte Et du Sujet Âgé, AP-HP, Hôpital Corentin Celton, Issy-Les-Moulineaux, 92130, France.
Séverine GilbertService de Psychiatrie Et d'Addictologie de L'adulte Et du Sujet Âgé, AP-HP, Hôpital Corentin Celton, Issy-Les-Moulineaux, 92130, France.
Frédéric LimosinService de Psychiatrie Et d'Addictologie de L'adulte Et du Sujet Âgé, AP-HP, Hôpital Corentin Celton, Issy-Les-Moulineaux, 92130, France.
Laurence LacosteService de Psychiatrie de L'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, 75004, France.
Diane RibayrolService de Psychiatrie de L'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, 75004, France.
Charles Ouazana VedrinesService de Psychiatrie de L'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, 75004, France.
Victor PitronUniversité Paris Cité, VIFASOM (Vigilance Fatigue Sommeil Et Santé Publique), Paris, France.
Karima Mesbahi-IhadjadeneUnité de Recherche Clinique Cochin, Hôpital Cochin, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, Université Paris Cité, 24 rue du Faubourg Saint Jacques, et URP7323, Paris, 75014, France.
Hendy AbdoulUnité de Recherche Clinique Cochin, Hôpital Cochin, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, Université Paris Cité, 24 rue du Faubourg Saint Jacques, et URP7323, Paris, 75014, France.
Jessica RousseauUnité de Recherche Clinique Cochin, Hôpital Cochin, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, Université Paris Cité, 24 rue du Faubourg Saint Jacques, et URP7323, Paris, 75014, France.
Alexandra KachanerUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, 75004, France.
Brigitte RanqueUniversité Paris Cité and Université Sorbonne Paris Nord, Inserm, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, 75004, France.
Patricia ThoreuxCIMS (Centre d'Investigations en Médecine du Sport), APHP, Hôpital Hôtel Dieu, Paris, 75004, France.
Cédric LemogneService de Psychiatrie de L'adulte, AP-HP, Hôpital Hôtel-Dieu, Paris, 75004, France. cedric.lemogne@aphp.fr.

Funding

Assistance Publique - Hôpitaux de Paris AAP CoVID-1
6 · The paper itself

Abstract

backgroundEffective rehabilitation programs targeting transdiagnostic mechanisms of persistent physical symptoms are needed in long COVID. We present a transparency-focused description of the protocol of an open-label randomized controlled trial designed to evaluate the efficacy and tolerance of a multidisciplinary intensive rehabilitation program versus usual care.

methodsAfter a day-hospital multidisciplinary evaluation program including minimal psychoeducation and personalized recommendations, patients presenting with persistent symptoms after COVID-19 are proposed to participate to the study. The intervention consists of a 6-week rehabilitation program with groups of 3 to 5 patients attending three day-hospital sessions per week. The rehabilitation program combines adapted physical activity (three sessions per week with progressive exertion thresholds), cognitive remediation (two computer-based personalized sessions per week) and cognitive behavioral therapy (CBT, two sessions per week: one group session and one individual session). CBT sessions encompass psychoeducation, cognitive restructuring, behavioral activation and gradual exposure, and problem-solving skills. Our primary outcome is health-related quality of life (HRQoL) at 6 months, measured with the Physical Component Score (PCS) of the 12-item Short-Form Health Survey. The secondary outcomes are the Mental Component Score (MCS) at 6 months, PCS and MCS at 3 months, the main persistent symptoms (fatigue, dyspnea, cognitive complaints, pain) and associated psychological burden at 3 and 6 months, and patients’ satisfaction at 3 months. All included patients undergo an inclusion visit including a physical condition evaluation, a neuropsychological assessment, a first consultation with the CBT therapist, and the completion of several questionnaires for the secondary outcomes (Pichot scale, Borg scale, Cognitive Difficulties Scale, pain numeric scale, and Somatic Symptom disorder-B criteria scale). These evaluations are repeated at 3- and 6-month follow-up. All analyses will be performed in intention to treat following CONSORT Statement recommendations. DISCUSSION: Our goal is to demonstrate that a multidisciplinary intensive rehabilitation program combining adapted physical activity, cognitive remediation, and CBT leads to an improvement in HRQoL in the long term (i.e., six months after a multidisciplinary evaluation program including minimal psychoeducation and personalized recommendations) in patients with long COVID, while being feasible, acceptable, and safe.

trial registrationNCT number NCT05532904, registration date: 2022–09-07.

Indexed as

Cognitive Behavioral TherapyCognitive RemediationCOVID-19Exercise TherapyCognitive TrainingFemaleHumansPandemicsPost-Acute COVID-19 SyndromeQuality of LifeSARS-CoV-2Treatment OutcomeAdapted physical activityCBTClinical trialCognitive remediationLong COVIDMultidisciplinary care

Identifiers

PMID41413915
PMCPMC12860058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.